Viewing Study NCT04194359

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-01-20 @ 12:35 PM
Study NCT ID: NCT04194359
Status: UNKNOWN
Last Update Posted: 2023-03-17
First Post: 2019-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
None RAS Mutation View
None Microsatellite Stable View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RAS-mutant Metastatic Colorectal Cancer View
None Immunotherapy View
None Anti-PD-1 View
None Checkpoint View
None Efficacy View
None Safety View
None Microsatellite stable View